Shares of Novo Nordisk, maker of Wegovy, rise after approval of GLP-1 pill
Novo Nordisk shares rose more than 7% on Tuesday after the Wegovy maker secured approval for its GLP-1 pill, a…
markets
Trump confirms possible drug reclassification, but stocks fall
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on US President Joe Biden “to…
Why Wall Street and Jim Cramer Think Danaher Stock Is 'Ready to Play'
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
Rivian's AI and autonomy impress, but not enough to offset concerns about electric vehicles
Rivian CEO RJ Scaringe at the company's first “Autonomy and AI Day” on December 11, 2025 in Palo Alto, California.…
Jim Cramer has faith in Danaher's turnaround as life sciences come back to life
Life sciences stocks are experiencing a resurgence, and that's good news for Danaher. Connecting the dots with better times ahead…
Air traffic controllers still missing after government shutdown
Planes line the runway at LaGuardia Airport on November 10, 2025 in New York City. Spencer Platt | Getty Images…
Yum Brands (YUM) Q3 2025 Earnings
The posters are displayed outside Yum! Brands Inc. Taco Bell and Kentucky Fried Chicken (KFC) restaurant in Louisville, Kentucky, USA,…
Halloween chocolate candies affected by inflation, tariffs and high cocoa prices
A customer buys Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas. Brandon Bell | fake…
We're raising our Eli Lilly price target – what a difference a quarter makes!
Eli Lilly shares rose Thursday after the drugmaker posted a strong third quarter, boosted by sales of its popular GLP-1…
Stocks of breast cancer drug Olema could more than double from now on, analysts say
Wall Street is optimistic that Olema Pharmaceuticals could be developing the next big breakthrough in breast cancer treatment. Earlier this…